← Leaderboards
Alessandro Grattoni
Methodist Hospital Research Institute
$14,325,435
Attributed
$19,704,493
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,704,493 · 8
By mechanism
R01$18,260,110 · 6
R24$846,258 · 1
R21$598,125 · 1
Top collaborators
- Norma Sue Kenyon4 shared
- Xuewu Liu4 shared
- Joan Elizabeth Nichols4 shared
- Patrick S. Stayton3 shared
- Ying Xuan Chua1 shared
Others in their field
Top investigators on “Membrane”
- Dennis R. Burton · Scripps Research Institute$258,610,184
- Barton F Haynes · Duke University$123,162,119
- Ted Ross · University Of Georgia$71,962,304
- Robert M Stroud · University Of California, San Francisco$63,701,163
- Dennis L. Kasper · Harvard Medical School$58,511,900
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$56,839,058
Research focus
MembranePharmaceutical PreparationsImplantDrug KineticsRegimenTechnologyDrug Delivery SystemsPumpDoseSubcutaneousSafetyInnovationDesignNonhuman PrimateIn VitroClinical TranslationNanochannelMinimally InvasiveRattusFutureFormulationClinical DevelopmentPolymersPre-Clinical
Grant awards (28)
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure$1,801,942
R01 · FY2025 · AI · contact PI
Center for the Dissemination of Ultra-Long-Acting Antiretroviral Release Technology: DART Resource Program$846,258
R24 · FY2025 · AI · contact PI
Long-acting multi prevention implant for 2-year contraception and HIV PrEP$817,162
R01 · FY2025 · AI · contact PI
Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes$754,051
R01 · FY2025 · DK · contact PI
Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes$697,245
R01 · FY2025 · DK · contact PI
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure$948,687
R01 · FY2024 · AI · contact PI
Long-acting multi prevention implant for 2-year contraception and HIV PrEP$816,407
R01 · FY2024 · AI · contact PI
Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes$769,293
R01 · FY2024 · DK · contact PI
Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes$669,652
R01 · FY2024 · DK · contact PI
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure$900,458
R01 · FY2023 · AI · contact PI
Long-acting multi prevention implant for 2-year contraception and HIV PrEP$830,671
R01 · FY2023 · AI · contact PI
Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes$775,293
R01 · FY2023 · DK · contact PI
Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes$698,529
R01 · FY2023 · DK · contact PI
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure$808,087
R01 · FY2022 · AI · contact PI
Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes$798,092
R01 · FY2022 · DK · contact PI
Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes$712,661
R01 · FY2022 · DK · contact PI
A nanofluidic platform for tunable drug delivery$338,921
R01 · FY2021 · GM · contact PI
A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis$761,083
R01 · FY2020 · AI · contact PI
A nanofluidic platform for tunable drug delivery$395,723
R01 · FY2020 · GM · contact PI
A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis$769,740
R01 · FY2019 · AI · contact PI
A nanofluidic platform for tunable drug delivery$412,720
R01 · FY2019 · GM · contact PI
A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis$764,063
R01 · FY2018 · AI · contact PI
A nanofluidic platform for tunable drug delivery$425,438
R01 · FY2018 · GM · contact PI
A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis$774,335
R01 · FY2017 · AI · contact PI
A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis$819,857
R01 · FY2016 · AI · contact PI
A tunable delivery platform for in vivo investigation of therapeutics$199,375
R21 · FY2016 · GM · contact PI
A tunable delivery platform for in vivo investigation of therapeutics$199,375
R21 · FY2015 · GM · contact PI
A tunable delivery platform for in vivo investigation of therapeutics$199,375
R21 · FY2014 · GM · contact PI